Efficacy of Vitrectomy Combined with Subretinal rtPA Injection with Gas or Air Tamponade

Klin Monbl Augenheilkd. 2017 Apr;234(4):487-492. doi: 10.1055/s-0042-121575. Epub 2017 Jan 31.

Abstract

Background Functional and anatomical outcome after vitrectomy with rtPA combined with gas or air tamponade. Patients and methods Retrospective analysis of pseudophakic patients treated with subretinal rtPA and gas or air tamponade. The primary endpoint was displacement of haemorrhage six months after surgery. The secondary endpoints were visual acuity (BCVA), haemorrhage diameter (MHD) and central macular thickness (CMT), as measured by SD-OCT. Results 53 of 85 eyes were pseudophakic. 27 of these eyes were treated with air tamponade and 26 with gas tamponade. For patients with air tamponade, the mean BCVA improved from 20/530 to 20/355 (p = 0.01). MHD and CMT decreased from 6386 ± 2281 µm to 3805 ± 2397 µm (p < 0.001) and 895 ± 592 µm to 532 ± 386 µm (p < 0.001), respectively. For patients with gas tamponade, the mean BCVA improved only slightly, from 20/471 to 20/394 (p = 0.17). MHD and CMT exhibited statistically significant decreases from 6759 ± 1773 µm to 3525 ± 1548 µm (p < 0.001) and 1089 ± 587 µm to 537 ± 251 µm (p < 0.001), respectively. Conclusions Vitrectomy with subretinal rtPA injection has strong functional and anatomical effects on submacular haemorrhages with both gas and air tamponade.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Air
  • Combined Modality Therapy / methods
  • Endotamponade / methods*
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Gases / therapeutic use
  • Humans
  • Intravitreal Injections
  • Male
  • Middle Aged
  • Recombinant Proteins / administration & dosage
  • Retinal Hemorrhage / diagnosis*
  • Retinal Hemorrhage / therapy*
  • Tissue Plasminogen Activator / administration & dosage
  • Treatment Outcome
  • Visual Acuity / drug effects
  • Vitrectomy / methods*

Substances

  • Fibrinolytic Agents
  • Gases
  • Recombinant Proteins
  • Tissue Plasminogen Activator